RP-HPLC raises a handful of sensible questions. This page answers them in order, starting with the fundamentals and moving to applications.
Reviewed 2026-05-05. Anything still debated is marked as such rather than presented as settled.
Reports on this compound commonly follow serum growth hormone and insulin-like growth factor 1 across defined time windows. Protocols differ in sampling frequency, assay platform, and participant characteristics, which makes direct comparison between publications difficult. Some work focuses on pulsatile release patterns instead of average concentrations. Whether repeated exposure alters endogenous hormone rhythms over long periods remains an open question, and the formal literature is thinner than the volume of informal commentary implies.
Once in circulation, the peptide binds the growth hormone-releasing hormone receptor displayed on pituitary somatotroph cells. Receptor activation couples to Gs proteins, elevates intracellular cyclic AMP, and drives protein kinase A signaling inside the cell. That cascade increases discharge of growth hormone into the bloodstream. The analog therefore operates through a receptor pathway that already exists for the body's own releasing hormone, rather than through an engineered artificial target.
The core sequence keeps the receptor-binding region of GHRH while replacing four positions that are vulnerable to dipeptidyl peptidase-4 and other proteases. Substitutions at positions 2, 8, 15, and 27 raise metabolic stability relative to the natural hormone. The N-terminal residues remain essential for activity, so changes there generally lower potency. Molecular weight sits near 3368 daltons for the tetrasubstituted analog without the linker, while the albumin-binding form is heavier because of the added maleimide group.
CJC-1295 is a synthetic peptide modeled on growth hormone-releasing hormone, the hypothalamic signal that prompts the pituitary to release growth hormone. Its sequence corresponds to the first twenty-nine residues of human GHRH, with four substitutions that slow enzymatic breakdown. Early descriptions placed the compound in research on growth hormone deficiency and related conditions, and later literature groups it with the long-acting GHRH analogs. The name appears in both laboratory and popular fitness writing, where it sometimes labels chemically different peptides.
Two related peptides circulate under the CJC-1295 label, and they differ mainly in how long they persist in circulation. The version carrying a drug affinity complex includes a maleimidopropionic acid linker that forms a covalent bond with serum albumin. The other version, usually written as modified GRF(1-29) or tetrasubstituted GRF(1-29), lacks that linker and is cleared quickly. Mixing the two produces inconsistent readings of published half-life values, because the linker rather than the receptor-facing sequence drives most of the difference.
| Property | Value | Notes |
|---|---|---|
| Primary target | GHRH receptor | Present on pituitary somatotroph cells |
| Signal pathway | Gs, cyclic AMP, protein kinase A | Sequence follows receptor activation |
| Main measured effect | Growth hormone release | Insulin-like growth factor 1 shifts indirectly |
| Half-life, binding form | Several days | Extended through serum albumin association |
| Half-life, unmodified form | About 30 minutes | Limited mainly by enzymatic cleavage |
The drug affinity complex is a maleimidopropionic acid group attached to a lysine side chain. It reacts with the free thiol of cysteine-34 on circulating albumin, forming a covalent bond. This conjugation keeps the peptide in the bloodstream and shields it from rapid renal filtration and proteolysis. Reported circulation half-lives for the albumin-bound form fall in the range of roughly six to nine days in early human studies.
Binding to GHRH receptors on pituitary somatotroph cells triggers cyclic AMP signaling and stimulates growth hormone synthesis and release. Because the peptide acts upstream of the pituitary, effects are mediated through endogenous growth hormone rather than direct receptor activation in peripheral tissues. Increases in insulin-like growth factor 1 are generally described as a downstream consequence. Most published human exposure data come from small early-stage studies, and the clinical significance of the pharmacokinetic profile remains incompletely characterized.
CJC-1295 is a synthetic analogue of growth hormone-releasing hormone, built on the 29-amino-acid GHRH(1-29) fragment. Four substitutions distinguish it from the natural sequence: D-alanine at position 2, glutamine at position 8, alanine at position 15, and leucine at position 27. These changes reduce enzymatic cleavage and extend the peptide's persistence in circulation. The compound is discussed in two forms, one carrying a drug affinity complex and one without it.
Identity and purity are established with reversed phase high performance liquid chromatography coupled to mass spectrometry. The chromatographic step separates the target peptide from truncated sequences and deletion products, while the mass measurement confirms the expected molecular weight to within a fraction of a dalton. Because the two common variants differ by the presence of the linker, mass alone can distinguish them in the unconjugated state. Amino acid analysis and peptide mapping are used when sequence level confirmation is required.
Lyophilized material is generally stable for extended periods when held at minus twenty degrees Celsius or below and protected from moisture and light. In solution the peptide is more labile; bond hydrolysis, aggregation and oxidation of susceptible residues all proceed faster at ambient temperature. Repeated freeze and thaw cycles should be avoided because they promote clumping and loss of soluble material. The conjugated variant adds a further consideration, since the maleimide group can hydrolyze in aqueous buffer and lose its ability to react with albumin.
=== "Winner" of the Space Race === The question of who won the Space Race has sparked considerable debate among historians and analysts. The United States is widely seen as the victor due to the Apollo crewed landing and moonwalk missions, which achieved President John F. Kennedy's ambitious goal of landing a man on the Moon and returning him safely to Earth by the end of the 1960s. This achievement, completed in July 1969, marked the pinnacle of U.S. space exploration efforts of the time and was regarded by most observers as the culmination of the Space Race. American political scientist Richard J. Samuels describes Apollo 11 as a "decisive American victory."
Pakistan and Bangladesh have experienced strained relations, particularly under the Awami League governments led by Sheikh Hasina, driven by her pro-India stance and historical grievances. Pakistan, a prominent member of the Organisation of Islamic Cooperation (OIC), prioritises maintaining cultural, political, social, and economic relations with Arab and other Muslim-majority nations in its foreign policy. In September 2025, Pakistan and Saudi Arabia signed a Strategic Mutual Defence Agreement under which any aggression against one country is considered an aggression against both, formalising a defensive commitment that also extends Pakistan's nuclear umbrella to Saudi Arabia.
==== Russia ==== On 26 October, a Russian Il-76 transport aircraft under US sanctions landed in Venezuela "after a circuitous route over Africa to avoid Western airspace, according to Flightradar24". The aircraft carried Pantsir-S1 and Buk-M2E air defense systems, according to a Russian official.
== History == DART resulted from conversations between Laramee and Cody about the development of an atmospheric pressure ion source to replace the radioactive sources in handheld chemical weapons detectors. DART was developed in late 2002 to early 2003 by Cody and Laramee as a new atmospheric pressure ionization process, and a US patent application was filed in April 2003. Although the development of DART actually predated the desorption electrospray ionization (DESI) ion source, the initial DART publication did not appear until shortly after the DESI publication, and both ion sources were publicly introduced in back-to-back presentations by R. G. Cooks and R. B. Cody at the January 2005 ASMS Sanibel Conference. DESI and DART are considered as pioneer techniques in the field of ambient ionization, since they operate in the open laboratory environment and do not require sample pretreatment. In contrast to the liquid spray used by DESI, the ionizing gas from the DART ion source contains a dry stream containing excited state species.
=== Plastic packaging violation case === In 2011, the Supreme Court of India issued a contempt notice to Dharampal Satyapal Limited for allegedly violating a ban on the use of plastic sachets for selling products. A representative from the Centre for Public Interest Litigation, the non-governmental organisation that originally filed the petition, claimed that the company attempted to circumvent the ban by labeling plastic-packaged products as "for export only," while they were instead sold domestically.
Sources: en.wikipedia.org
=== July === July 27, 2011: United Kingdom After figures showed that the 0.5% contraction in Q4 2010 was cancelled out by a 0.5% rise in Q1 2011, growth estimates from the ONS suggest that the growth in the UK is slowing down, after figures of 0.2% GDP increase was posted. Sovereign debt in the Eurozone and EU cause the stock market to crash from a FTSE-100 high of 6100 points to just above 5000.
Many medical procedures are called minimally invasive; those that involve small incisions through which an endoscope is inserted, end in the suffix -oscopy, such as endoscopy, laparoscopy, arthroscopy. Other examples of minimally invasive procedures include the use of hypodermic injection, and air-pressure injection, subdermal implants, refractive surgery, percutaneous surgery, cryosurgery, microsurgery, keyhole surgery, endovascular surgery using interventional radiology (such as angioplasty or embolization), coronary catheterization, permanent placement of spinal and brain electrodes, stereotactic surgery, the Nuss procedure, radioactivity-based medical imaging methods, such as gamma camera, positron emission tomography and SPECT (single photon emission tomography). Related procedures are image-guided surgery, and robot-assisted surgery.
On April 7, 1994, Federal Express Flight 705 bound for San Jose, California, experienced an attempted hijacking shortly after takeoff. FedEx employee Auburn Calloway tried to hijack the plane in order to crash it into the FedEx hub at Memphis International, in a Kamikaze-style attack. The crew—although seriously injured—fought him off and returned to Memphis, where police and emergency crews subdued him. On October 15, 2002, a Northwest Airlines Avro RJ 85 collided with the jetway at gate C2 while taxiing for a maintenance check. The mechanics were unable to slow the aircraft down in time. Due to their error, the aircraft suffered minor damage, but the number one engine was ripped almost entirely off, and the jetway. The aircraft was eventually torn apart and set in a field near the airport. On December 18, 2003, FedEx Express Flight 647 veered off the runway after the landing gear collapsed upon landing. The flight had departed Oakland International Airport (OAK) earlier that day. The aircraft was immediately engulfed in flames. All five crew members escaped by exiting via the cockpit window. On July 28, 2006, FedEx Flight 630's landing gear collapsed upon landing at Memphis International Airport after a flight from Seattle–Tacoma International Airport. After coming to a stop, the plane caught fire, engulfing the left wing and engine. While the three crew members sustained injuries, they all survived. The aircraft was written off.
===== Stimulation of natural killer (NK) cells ===== Experiments with UV-inactivated SeV showed that NK cells are important in virus-mediated inhibition of tumor growth. This was shown in a mouse model of renal cancer, in which the anti-tumor effect of SeV was suppressed by reducing the number of NK cells by co-injection of specific antibodies. The activation of NK requires several receptors, among which are natural killer proteins 46 (NKp46) and 44 (NKp44). Studies have shown that the only paramyxovirus protein that activates NK is HN. HN protein binding to NKp46 and/or NKp44 results in the lysis of cells whose surfaces display the HN protein or its fragments. It can be assumed that NK activation and tumor suppression by UV-treated SeV are caused by interaction between HN belonging to SeV, and NKp46 and/or NKp44 receptors belonging to NK cells.
Sources: en.wikipedia.org
It acts on the growth hormone-releasing hormone receptor found on pituitary somatotroph cells. Activation of that receptor triggers growth hormone release through a cyclic AMP dependent pathway.
It links the peptide to serum albumin after administration, which delays removal from circulation. Reported half-life shifts from roughly half an hour to several days as a result.
Most published work tracks serum growth hormone and insulin-like growth factor 1 over time. Sampling schedules and assay methods vary enough that figures are not directly comparable across reports.
Natural GHRH is degraded quickly by dipeptidyl peptidase-4 and related enzymes, giving it a half-life measured in minutes. CJC-1295 carries substitutions that slow that breakdown, so it stays intact longer. Both act at the same pituitary receptor and produce the same class of signal.